Deep Sedation
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
1 program
ERPS, BIS and Entropy for Neuromonitoring in ICU PatientsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
EppendorfPK analysis
GE HealthCareERPS, BIS and Entropy for Neuromonitoring in ICU Patients
Clinical Trials (2)
Total enrollment: 45 patients across 2 trials
Pharmacokinetic Analysis of Midazolam and Fentanyl in Pediatric Patients With Long-term Analgosedation
Start: Oct 2014Est. completion: Oct 201825 patients
N/ACompleted
ERPS, BIS and Entropy for Neuromonitoring in ICU Patients
Start: Nov 2004Est. completion: Sep 200720 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.